First Wave Bio Inc. to Begin Clinical Trials of Novel SmallMolecule Therapy for Ulcerative Colitis

First Wave Bio Inc. a biopharmaceutical company developing novel therapeutics for the treatment of inflammatory bowel disease IBD and related autoimmune disorders today announced that it has received regulatory approval to begin cli...